Market Analysis

Positioning for the Next Leg of the AI Trade and Netflix Earnings

Experts analyze Netflix results, AI investment strategies, biotech mergers, and regulatory shifts in South Korea.

This episode covers investor positioning for the AI trade, analysis of Netflix's earnings, biotech M&A trends, and regulatory changes in South Korea.

12345
62 minJul 16, 2026Closing Bell

Prepared by GenPodAI-assisted and grounded in publisher-provided material

Listen to the original

Key takeaways

01

AI Trade Positioning

Andrew Goldberg explains how investors should position their portfolios as earnings season gains momentum, focusing on the next leg of the AI trade.

2
02

Netflix Earnings Analysis

Mark Mahaney analyzes Netflix's results, highlighting signals for growth, advertising performance, and implications for the broader media landscape.

3
03

Biotech M&A Trends

Michael Yee discusses the latest wave of biotech mergers and acquisitions, including Eli Lilly's move into psychedelics and where deal activity may accelerate.

4
04

South Korea ETF Ban

South Korea moves to ban new single-stock leveraged ETFs, impacting local market dynamics.

5
05

SpaceX Short Interest

Growing short interest in SpaceX suggests investors are debating whether early holders are hedging ahead of future share sales.

5

Ask GenPod next

Keep the question moving.

01

“What specific AI sectors are showing the strongest earnings momentum?”

02

“How does Netflix's advertising growth compare to its subscriber growth?”

03

“Which biotech companies are most likely to announce M&A deals next?”

Questions

Questions to carry into the episode.

How should investors position for the AI trade during earnings season?

Andrew Goldberg provides strategies for positioning as earnings season gathers momentum.

2
What do Netflix's earnings signal for the media landscape?

Mark Mahaney analyzes the results to determine signals for growth and advertising.

3
Where is biotech M&A activity accelerating?

Michael Yee discusses the latest wave of biotech M&A and potential acceleration points.

4
Why is there growing short interest in SpaceX?

Investors debate whether early holders are hedging ahead of future share sales.

5

Experts

Voices named in the source.

Andrew Goldberg

Chief Global Strategist at Nomura Asset Management

2

Mark Mahaney

Analyst at Evercore

3

Michael Yee

Analyst at UBS

4

Sources and disclosure

Where this guide comes from.

Primary material

Closing Bell Overtime: Positioning for the next leg of the AI trade; Netflix reports earnings 7/16/26

Closing Bell · Jul 16, 2026
How this guide was prepared

GenPod used an AI-assisted workflow to organize publisher-provided show notes into a listening guide. It is not independent reporting or fact-checking; verify important claims against the source episode.

Read our methodologyReport a correction
Source note

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

  1. Publisher show notes · Excerpt 1

    Investors weigh results from Netflix, Alcoa and Intuitive Surgical.

  2. Publisher show notes · Excerpt 2

    Andrew Goldberg, Chief Global Strategist at Nomura Asset Management, explains how investors should position as earnings season gathers momentum.

  3. Publisher show notes · Excerpt 3

    Evercore’s Mark Mahaney analyzes Netflix’s results and what they signal for growth, advertising and the broader media landscape.

  4. Publisher show notes · Excerpt 4

    Our Annika Kim Constantino reports on Eli Lilly's move into psychedelics while Michael Yee of UBS discusses the latest wave of biotech M&A and where deal activity could accelerate next.

  5. Publisher show notes · Excerpt 5

    Plus, a look at South Korea's move to ban new single-stock leveraged ETFs and growing short interest in SpaceX as investors debate whether early holders are hedging ahead of future share sales.

  6. Publisher show notes · Excerpt 6

    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Related listening guides

Choose what to hear next.